What’s on the agenda?
What’s coming up in the pharmacy calendar in 2023? Well, a major international pharmacy event is heading down under…. The world is coming to Brisbane The biggest international event in …
A blow for pharmacy, and patients
December 1972: Pharmacy suffers a defeat in its campaign to limit the number of analgesics distribution outlets. Meanwhile, the Guild modernises its leadership structure Pharmacy was delivered “an unexpected blow …
Feature focus
What were our best read features of 2022? AI, masks, DAAs and harm minimisation top the list Here are the ten best read Feature articles on the AJP website in …
Getting your attention
What were the the ten most popular episodes of the AJP podcast in 2022? In the next part of our series looking at our most popular articles in 2022, we …
Keeping educated
What were the ten most clicked CPD articles on our website in 2022? AJP’s CPD offerings have increased in quantity and variety to meet the needs of our readers. So …
Out with the old, in with the new
This is our final daily newsletter for 2022, but we have one special edition still to come. These are the dates you need to know These are the dates …
What you were reading
We kick off our review of what our readers have been looking at in 2022 by reviewing our 10 best read columns for the year These were the ten best …
Antibiotic substitution arrangement in force
New amoxicillin substitution amendments introduced as health system tries to deal with the ongoing shortage of the medicine The federal Department of Health and Aged Care has announced amendments to …
A need for training
While a majority of Australian pharmacists endorse the provision of low-dose cannabis-based medicines, most lack confidence in discussing them with patients and say they need more training A new Australian …
Report backs more hospital pharmacy roles
The Society of Hospital Pharmacists of Australia (SHPA) says it strongly supports an inquiry’s call for more expert pharmacist places in NSW hospitals The comments follow the release this week …
The week in review
There were moves to limit the influence of lobby groups, such as the Pharmacy Guild, while the number of overseas pharmacists applying for Australian visas reached new heights The week …
‘A clear risk to patient safety’
New AMA video criticises pharmacist prescribing trials, saying they could lead to second class care and more superbugs emerging The Australian Medical Association (AMA) has released a new video questioning …